NCT01984359View on ClinicalTrials.gov

HPV Serum DNA Levels Predicting Outcome in p16+ Squamous Cell Head and Neck Cancer

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

May 24, 2018

Conditions
Subjects With p16 Positive/HPV Positive Squamous Cell Carcinomas of the Oropharynx
Interventions
OTHER

Obtaining Human tissue

Trial Locations (1)

19104

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

Abramson Cancer Center at Penn Medicine

OTHER

NCT01984359 - HPV Serum DNA Levels Predicting Outcome in p16+ Squamous Cell Head and Neck Cancer | Biotech Hunter | Biotech Hunter